PreciseDx logo

PreciseDx

New York, NY

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes.

precisedx.ai

Company Details

Founded

2019

Employees

Between 20 - 50 employees

Raised

$42,680,072

Headquarters Location

New York, NY

Public

No

Acquired

No

CEO

Wayne BrinsterWayne Brinster

Founders

Carlos Cordon-Cardo
Carlos Cordon-Cardo
Gerardo Fernandez
Gerardo Fernandez
Michael Donovan
Michael Donovan
Jack Zeineh
Jack Zeineh

Company Collections

These are collections PreciseDx is a part of. Click on the collection name to view similar companies.

PreciseDx's Industries

PreciseDx's Tech Stack

PreciseDx Headquarters Location

1 Gustave L Levy Place Ny Ny, New York, NY 10029

Total Amount Raised: $42,680,072

PreciseDx Funding Rounds

  • Series B

    $11,230,074

    Series B Investors

    Eventide
    Merck
    GenHenn Venture
    Labcorp
    Philips
    Quest Diagnostics

  • Series B

    $20,700,000

    Series B Investors

    Eventide
    Quest Diagnostics
    GenHenn Venture
    Labcorp

  • Series A

    $10,750,000

    Series A Investors

    Merck
    Agilent Technologies
    Mount Sinai Health System
    IBM Ventures
Funding info provided by Diffbot.

PreciseDx Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on PreciseDx.

Recent reviews